Sign in to view content

Evaluation of Baseline Characteristics on Lesion Progression in a Large Phase 2 Clinical Trial for Geographic Atrophy (FILLY Study)

Eleonora Lad, MD, PhD

Video
Published 2019

Eleonora Lad

AMD Non-neovascular Symposium

Related

How Do I Decide to Treat Patients with Geographic Atrophy?
Glenn J. Jaffe, MD
Updates from the Field
2024
Frequency of Age-Related Macular Degeneration Risk Alleles Y402H and A69S in a Direct-to-Consumer Genetic Database
Theodore Leng, MD, MS, FASRS
Annual Meeting Talks
2019
Treatment of Geographic Atrophy Secondary to AMD With Pegcetacoplan: Two-Year Outcomes From the Randomized Phase 3 DERBY and OAKS Trials
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2022

Category: AMD-Non-Neovascular

See more